Crizotinib hydrochloride

Ref. 3D-QGC56069

Informations sur le produit

• Nom: Crizotinib hydrochloride
• Marque: Biosynth
• Description: Crizotinib hydrochloride (CZH) is an anti-cancer drug that inhibits the enzyme tyrosine kinase. It is a porphyrin-based molecule that has a linker to crizotinib, a cytotoxic agent. CZH has been approved for the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in adults who have received at least one prior therapy. The effective dose of CZH is 400 mg twice per day. CZH has shown anticancer activity in vitro and in vivo and low toxicity.

Propriétés chimiques

• Masse moléculaire: 486.8 g/mol
• Formule: C₂₁H₂₃Cl₃FN₅O
• Degré de pureté: Min. 95%